BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koyama S, Koike N, Adachi S. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma. J Cancer Res Clin Oncol. 2001;127:20-26. [PMID: 11206267 DOI: 10.1007/s004320000181] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lee TB, Min YD, Lim SC, Kim KJ, Jeon HJ, Choi SM, Choi CH. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells. J Gastroenterol Hepatol. 2002;17:32-38. [PMID: 11895550 DOI: 10.1046/j.1440-1746.2002.02657.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhu J, Lu L, Cheng X, Xie R, Chen Z, Li Y, Lin G, Liu J, Yang Y. Association between CD95L polymorphism and cervical cancer risk: evidence from a meta-analysis. Tumour Biol 2014;35:5137-42. [PMID: 24619598 DOI: 10.1007/s13277-014-1652-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Zhou RM, Wang N, Chen ZF, Duan YN, Sun DL, Li Y. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma. J Gastroenterol Hepatol 2010;25:555-61. [PMID: 20074157 DOI: 10.1111/j.1440-1746.2009.06116.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
4 Koyama S. Coordinate cell-surface expression of matrix metalloproteinases and their inhibitors on cancer-associated myofibroblasts from malignant ascites in patients with gastric carcinoma. J Cancer Res Clin Oncol 2005;131:809-14. [PMID: 16180025 DOI: 10.1007/s00432-005-0030-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
5 Wan Mohd Tajuddin WNB, Lajis NH, Abas F, Othman I, Naidu R. Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer. Nutrients 2019;11:E2989. [PMID: 31817718 DOI: 10.3390/nu11122989] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
6 He Y, Xu R, Peng L, Hu X. Tumor infiltrating lymphocytes associated competitive endogenous RNA networks as predictors of outcome in hepatic carcinoma based on WGCNA analysis. PLoS One 2021;16:e0254829. [PMID: 34324544 DOI: 10.1371/journal.pone.0254829] [Reference Citation Analysis]
7 Maher S, Toomey D, Condron C, Bouchier-Hayes D. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol Cell Biol. 2002;80:131-137. [PMID: 11940113 DOI: 10.1046/j.1440-1711.2002.01068.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 100] [Article Influence: 5.7] [Reference Citation Analysis]
8 Orozco-Morales M, Sánchez-García FJ, Golán-Cancela I, Hernández-Pedro N, Costoya JA, de la Cruz VP, Moreno-Jiménez S, Sotelo J, Pineda B. RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells. Cancer Cell Int 2015;15:57. [PMID: 26146488 DOI: 10.1186/s12935-015-0209-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jutzy JM, Khan S, Asuncion-Valenzuela MM, Milford TA, Payne KJ, Wall NR. Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro. Cancer Microenviron 2013;6:57-68. [PMID: 22322461 DOI: 10.1007/s12307-012-0096-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
10 Ge Z, Sanders AJ, Ye L, Jiang WG. Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer. Exp Ther Med. 2011;2:167-172. [PMID: 22977485 DOI: 10.3892/etm.2011.206] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
11 Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495-516. [PMID: 17562483 DOI: 10.1080/01926230701320337] [Cited by in Crossref: 6410] [Cited by in F6Publishing: 6035] [Article Influence: 427.3] [Reference Citation Analysis]
12 Grandics P. The cancer stem cell: evidence for its origin as an injured autoreactive T cell. Mol Cancer. 2006;5:6. [PMID: 16478542 DOI: 10.1186/1476-4598-5-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
13 Davidson B, Dong HP, Berner A, Risberg B, Layfield LJ. The diagnostic and research applications of flow cytometry in cytopathology. Diagn Cytopathol 2012;40:525-35. [DOI: 10.1002/dc.22809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Zhou L, Zhang G, Zhou X, Li J. The association between the SNP rs763110 and the risk of gynecological cancer: a meta-analysis. Biomed Pharmacother 2015;69:208-13. [PMID: 25661359 DOI: 10.1016/j.biopha.2014.11.022] [Reference Citation Analysis]
15 Koyama S. Flow cytometric measurement of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J Gastroenterol Hepatol. 2003;18:763-770. [PMID: 12795746 DOI: 10.1046/j.1440-1746.2003.03055.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
16 Strebel A, Bachmann F, Wernli M, Erb P. Tumor necrosis factor-related, apoptosis-inducing ligand supports growth of mouse mastocytoma tumors by killing tumor-infiltrating macrophages. Int J Cancer 2002;100:627-34. [DOI: 10.1002/ijc.10539] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
17 Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N. Apoptosis and molecular targeting therapy in cancer. Biomed Res Int. 2014;2014:150845. [PMID: 25013758 DOI: 10.1155/2014/150845] [Cited by in Crossref: 469] [Cited by in F6Publishing: 521] [Article Influence: 58.6] [Reference Citation Analysis]
18 Zhao T, Li W, Chen J, Qin W. Genomic variants in Fas-mediated apoptosis pathway predict a poor response to Platinum-based Chemotherapy for Chinese Gastric Cancer Patients. J Cancer 2021;12:849-59. [PMID: 33403042 DOI: 10.7150/jca.48120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kim R, Emi M, Tanabe K, Uchida Y, Toge T. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy. Cancer 2004;100:2281-91. [PMID: 15160330 DOI: 10.1002/cncr.20270] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
20 Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong P, Zhou Y, Lin D. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 2005;42:479-84. [PMID: 15937082 DOI: 10.1136/jmg.2004.030106] [Cited by in Crossref: 102] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
21 Toomey D, Smyth G, Condron C, Kelly J, Byrne AM, Kay E, Conroy RM, Broe P, Bouchier-Hayes D. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up. Int J Cancer 2003;103:408-12. [PMID: 12471625 DOI: 10.1002/ijc.10836] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
22 Li-Weber M, Krammer PH. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin Immunol. 2003;15:145-157. [PMID: 14563113 DOI: 10.1016/s1044-5323(03)00030-7] [Cited by in Crossref: 82] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
23 Sun BC, Zhao XL, Wang ZH, Liu YX, Wang X, Gu Q. Expression of Fas and p53 in different stages of large intestinal malignant transformation and their association with apoptosis. Shijie Huaren Xiaohua Zazhi 2004; 12(9): 2070-2073 [DOI: 10.11569/wcjd.v12.i9.2070] [Reference Citation Analysis]
24 Yu X, Li Y, Yu Y, Lei J, Wan G, Cao F. Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects. Onco Targets Ther 2016;9:2049-56. [PMID: 27103831 DOI: 10.2147/OTT.S102723] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Zhao WH, Wang SF, Ding W, Sheng JM, Ma ZM, Teng LS, Wang M, Wu FS, Luo B. Apoptosis induced by preoperative oral 5’-DFUR administration in gastric adenocarcinoma and its mechanism of action. World J Gastroenterol 2006; 12(9): 1356-1361 [PMID: 16552801 DOI: 10.3748/wjg.v12.i9.1356] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
26 Wang Y, Li JJ, Ba HJ, Wang KF, Wen XZ, Li DD, Zhu XF, Zhang XS. Down Regulation of c-FLIPL Enhance PD-1 Blockade Efficacy in B16 Melanoma. Front Oncol 2019;9:857. [PMID: 31552181 DOI: 10.3389/fonc.2019.00857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ganten TM, Aravena E, Sykora J, Koschny R, Mohr J, Rudi J, Stremmel W, Walczak H. Helicobacter pylori-induced apoptosis in T cells is mediated by the mitochondrial pathway independent of death receptors. Eur J Clin Invest. 2007;37:117-125. [PMID: 17217377 DOI: 10.1111/j.1365-2362.2007.01761.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]